Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy

@article{Coaa2014MyeloidderivedSC,
  title={Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy},
  author={Yago Pico de Coa{\~n}a and Giuseppe V Masucci and Johan Hansson and Rolf Kiessling},
  journal={Cancer Immunology, Immunotherapy},
  year={2014},
  volume={63},
  pages={977-983}
}
Immune checkpoints are a series of inhibitory pathways that are crucial for modulating the intensity and duration of immune response. Among these checkpoints, cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) has been shown to be a key regulator of the early activation of naïve and memory T cells. Immune checkpoint blockade is emerging as one of the most promising therapeutic approaches directed toward the activation of the immune response against tumors. The first of these therapies that… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 62 references

Tw, sakaguchi s

T Takahashi, T Tagami, +4 authors Mak
J exp Med • 2000
View 8 Excerpts
Highly Influenced

CTLA-4 is a second receptor for the B cell activation antigen B7

The Journal of experimental medicine • 1991
View 6 Excerpts
Highly Influenced

The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation

Blank Cu
Curr Opin Oncol • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…